|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Novel use of rituximab in a ease of Riedel's thyroiditis refractory to glucoeortieoids and tamox- ifen 显示文摘 | Soh SB1 Pham A O'Hehir RE | 2013 | J Clin Endoerinol Metab2013，98，9： | 1 |
| 2 | A randomized,double-blind,placebo-controlled,phase Ⅲb trial (ATLAS) comparing bevacizumab (B) therapy with or without erlotinib (E) after completion of chemotherapy with B for first-line treatment of locally advanced,recurrent,or metastatic non-small cel显示文摘 | Miller VA O'Connor P Soh C | | 0，，8002： | 1 |
| 3 | Identification of the bac- terial microflora in dairy products by temporal tempera- ture gradient gel electrophoresis显示文摘 | Ogier J C Soh O Gruss A | 2002 | Applied and Envi- ronmental Microbiology2002，68，： | 1 |
| 4 | A randomized, double- blind, placebo- controlled, phase IIIb trial (ATLAS) comparing bevacizumab (B) therapy with or without erlotinib (E) after completion of chemotherapy with B for first - line treatment of locally advanced, recurrent, or metastatic non -small cell lung cancer (NSCLC) 显示文摘 | Miller VA O'Connor P Soh C | 2009 | J Clin Oncol2009，27，18： | 1 |
| 5 | A randomized, double- blind, placebo-controlled, phase III b trial (ATLAS) comparing bevacizumab (13) therapy with or without erlotinib (E) after completion of chemotherapy with B for first-line treatment of locally advanced, recurrent, or metastatic non- small cell lung cancer (NSCLC) 显示文摘 | Miller VA O'Connor P Soh C | 2009 | J Clin Oncol2009，27，18： | 1 |
| 6 | Enhancing fraction in glioma and its relationship to the tumoral vascular mieroenviron- ment: A dynamic contrast-enhanced MR imaging study 显示文摘 | Mills S J Soh C O'Connor J P | 2010 | AJNR2010，31，4： | 1 |
| 7 | Identification of active Plasmodium falciparum calpain to establish screening system for Pf-calpain-based drug development显示文摘 | Soh B Y Song H O Lee Y Lee J Kaewintajuk K Lee B Choi Y Y Cho J H Choi S Park H | 2013 | Malaria Journal2013，12，1： | 1 |
| 8 | A randomized, double-blind, placebo-controlled, phase Ⅲ b trial (ATLAS) comparing bevacizumab (B) therapy with or without erlotinib (E) after completion of chemotherapy with B for first-line treatment of locally advanced, recurrent, or metastatic non-small cell lung cancer (NSCLC)显示文摘 | Miller VA O'Connor P Soh C | 2009 | J Clin Oncol 27:18s2009，8002，： | 1 |
| 9 | Enhancing fraction in glioma and its relationship to the tumoral vascular microenvironment: a dynamic contrast-enhanced MR imaging study显示文摘 | Mills SJ Soh C O'Connor JP | 2010 | AJNR2010，31，4： | 1 |
| 10 | Assembly feature design in an augmented reality environment显示文摘 | Pang Yan Andrew Y C Soh K O | | 0，，01： | 1 |
| 11 | Graphcut textures:Image and video synthesis using graph cuts显示文摘 | V Kwatra A Soh(o)dl I Essa | 2003 | ACM Trans on Graphics (TOG)2003，22，3： | 1 |
| 12 | Life history and reproduction of synchelidium lenorostralum (Amphipoda, Oedicerotidae) in a temperate sandy shore, southern Korea 显示文摘 | Yu O H Soh H Y Suh H L | 2002 | Journal of Crustacean Biology2002，22，1： | 1 |
| 13 | A randomized, double-blind, placebo-controlled, phase ⅢB trial (ATLAS) comparing bevacizumab ( B ) therapy with or without erlotinib ( E ) after completion of chemotherapy with B for first-line treatment of locally advanced, recurrent, or metastatic non-small cell lung cancer显示文摘 | Miller VA O' Connor P Soh C | 2009 | J Clin Oncol2009，27，18： | 1 |
| 14 | Genetic transformation and plant regeneration of watermelon using Agrobacterium tumefaciens显示文摘 | CHOI P S SOH W Y KIM Y S YOO O J LIU J R | 1994 | Plant Cell Reports1994，13，： | 1 |
| 15 | A randomized, double-blind, placebo-controlled, phase trial(ATLAS) comparing bevaeizumab(B) therapy with or without erlo- tinib(E) after completion of chemotherapy with B for first-line treatment of locally advanced, recurrent, or me- tastatic non-small cell lung cancer (NSCLC) 显示文摘 | Miller VA O'Connor PG Soh C | 2009 | J Clin Oncol2009，27，18： | 1 |
| 16 | A randomized,double-blind,placebo-controlled,phase Ⅲb trial (ATLAS) comparing bevacizumab (B) therapy with or without erlotinib (E)after completion of chemotherapy with B for first-line treatment of locally advanced,recurrent,or metastatic non-small cell显示文摘 | Miller VA O'Connor P Soh C | | 0，，18： | 1 |
| 17 | A randomized, double-blind, placebo-controlled, phase IIIb trial (AT- LAS) comparing bevacizumab (B) therapy with or without erlotinib (E) after completion of chemotherapy with B for first-line treatment of locally advanced, recurrent, or me- tastatic non-small cell lung cancer (NSCLC) 显示文摘 | Miller VA O'Connor P Soh C | 2009 | J Clin Oncol2009，27，18： | 1 |
| 18 | A randomized,double-blind,placebo-controlled,phase Ⅲb trial (ATLAS) comparing bevacizumab (B) therapy with or without erlotinib (E) after completion of chemotherapy with B for first-line treatment of locally advanced,recurrent,or metastatic non-small cell lung cancer (NSCLC)显示文摘 | Miller VA O'Connor P Soh C | 2009 | J Clin Oncol2009，27，1： | 1 |
| 19 | The Synthesis of Six-B~ Linkages as Constrained Planar 3R Chains 显示文摘 | Soh O S McCarthy I M | 2008 | Mechanism and Machine Theory2008，43，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员